Alethea Capital Management, LLC Gilead Sciences, Inc. Transaction History

Alethea Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $448,741 - $489,586	6,069 New	6,069 $454,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $510,822 - $575,338	8,850 New	8,850 $547,000
Q3 2021 Oct 27, 2021	SELL	$67.69 - $73.03 $781,007 - $842,620	-11,538 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $732,316 - $800,160	11,538 New	11,538 $795,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $295,320 - $336,960	-4,922 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $846,804 - $964,893	-14,948 Reduced 75.23%	4,922 $287,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.23 Million - $1.55 Million	19,870 New	19,870 $1.26 Million
Q1 2018 Apr 18, 2018	SELL	$72.84 - $88.8 $980,717 - $1.2 Million	-13,464 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $957,963 - $1.12 Million	13,464	13,464 $965,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alethea Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alethea Capital Management, LLC with notifications on news.